Research about the onset mechanism of the gastric cancer after the antimicrobial treatment for Helicobacter pylori.

Research about the onset mechanism of the gastric cancer after the antimicrobial treatment for Helicobacter pylori. - Research about the onset mechanism of the gastric cancer after the antimicrobial treatment.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000027524

Enrollment

100

Registered

2017-06-01

Start date

2017-06-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gstric cancer and chronic gastritis after the Helicobacter pylori antimicrobial treatment

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients whom gastric cancer developed in after antimicrobial treatment for Helicobacter pylori and control group after antimicrobial treatment that matched the number of years,sex,age.

Exclusion criteria

Exclusion criteria: Exclusion criteria are history of gastrectomy, and patients with gastric cancer or other malignant lesions, pylori-positive,hemorrhagic diseases, cirrhosis or renal failure.

Design outcomes

Primary

Measure	Time frame
The gene expression causing the map-like redness and a background gastric mucosa associated with the second cancer outbreak after the Helicobacter pylori antimicrobial treatment.	—

Secondary

Measure	Time frame
New biomarkers associated with the second cancer outbreak after the Helicobacter pylori antimicrobial treatment.	—

Countries

Japan

Contacts

Public ContactKyosuke Goda

Kawasaki Medical School Division of Gastroenterology Department of Internal Medicine

gooooo_ddy@yahoo.co.jp086-462-1111

Outcome results